Abstract
Despite the potentially serious outcome of malignant GTD, most women with all forms of GTD can be successfully diagnosed and treated, with preservation of their normal reproductive function. It is important to manage hydatidiform mole properly in order to mini-mize acute complications, identify malignant sequelae promptly, and begin therapy. It is important to individu-alize therapy for women with malignant GTD based upon known risk factors, using less toxic therapy for patients with low-risk disease and aggressive multiagent therapy for patients with high-risk disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Gynecology and Obstetrics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
